fda approves semaglutide has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for 🟣 FDA Approves Wegovy HD

SS-OCT (Triton) generally reports numerically greater values regarding these parameters than SD-OCT (Spectralis) due to deeper penetration, longer wavelength, and differing segmentation algorithms [16,17,18]

Blood glucose monitoring and appropriate medication adjustments can prevent these episodes

During Weeks 14, appetite control, lower-calorie intake, and improved fasting glucose help establish your metabolism

Visual analogue scales (VAS) for hunger, fullness, and prospective food consumption show significant differences versus placebo

Regardless of the specific injectable product, the principle of starting low and increasing slowly remains paramount

If blood sugar drops too low, it can result in blurred vision